Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Laryngeal Neoplasms × adavosertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 5 Small Cell Lung Carcinoma 4 Advanced Solid Tumours 4 Neoplasms 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Fallopian Tube Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Advanced Malignant Solid Neoplasm 2 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple-negative Metastatic Breast Cancer 1 Stomach Neoplasms 1 Solid Tumors 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Muscle Invasive Bladder Cancer 1 Multiple Myeloma 1

Interventions

Cisplatin 28 Radiotherapy 17 Magnetic Resonance Spectroscopy 17 Cetuximab 16 Specimen Handling 14 pembrolizumab 12 Carboplatin 11 Radiotherapy, Intensity-Modulated 10 Fluorouracil 10 Docetaxel 9 Surgical Procedures, Operative 8 Platinum 8 1,2-diaminocyclohexaneplatinum II citrate 8 Radiation 7 Paclitaxel 7 Biopsy 7 Drug Therapy 5 toripalimab 4 Taxes 4 Standard of Care 4 (225)Ac-DOTA-c(RGDyK) 4 X-Rays 3 Nutritional Status 3 Laser Therapy 3 Immunohistochemistry 3 Fluorodeoxyglucose F18 3 Chemoradiotherapy 3 Celecoxib 3 130-nm albumin-bound paclitaxel 3 motexafin gadolinium 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03028766 2024-09-19

WISTERIA

University of Birmingham

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡